Lyka Labs informs about un-audited standalone financial results

03 Nov 2018 Evaluate

Lyka Labs has informed about copy of the Un-audited Standalone Financial Results of the Company for the Second Quarter and half year ended 30th September, 2018 which was taken on record by the Board of Directors at its meeting held on November 2, 2018 together with Limited Review Report by Auditors thereon. The meeting commenced at 7.00 pm and ended at 9.00 pm.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

143.35 2.55 (1.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.